We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,629 results
  1. Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer

    HPV vaccination with concomitant HPV-based screening of young women has been proposed for faster cervical cancer elimination. We describe the...

    Laila Sara Arroyo Mühr, Andrea Gini, ... Joakim Dillner in Nature Communications
    Article Open access 01 May 2024
  2. Analysis of age-specified and genotype distribution of HPV multiple infections in the Chinese population

    Multiple infections are a key component of HPV pathogenesis and have a direct impact on how an infection turns out. It’s crucial to look at the...

    Yu-**a Zhou, **ao-Hui Ma, ... **ao-Qian Zhang in Scientific Reports
    Article Open access 01 February 2024
  3. Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer

    Human papillomavirus (HPV) status strongly predicts positive clinical outcomes in patients with head and neck squamous cell cancer (HNSCC); however,...

    Zhongqiu Wang, Qingxin Wang, ... Peiguo Wang in Scientific Data
    Article Open access 12 October 2023
  4. Detecting and monitoring concerns against HPV vaccination on social media using large language models

    Health risks due to preventable infections such as human papillomavirus (HPV) are exacerbated by persistent vaccine hesitancy. Due to limited sample...

    Sunny Rai, Melanie Kornides, ... Sharath Chandra Guntuku in Scientific Reports
    Article Open access 21 June 2024
  5. LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma

    The increasing incidence of oropharyngeal squamous cell carcinoma (OPSCC) is primarily due to human papillomavirus, and understanding the tumor...

    Reija Randén-Brady, Timo Carpén, ... Suvi Silén in Scientific Reports
    Article Open access 19 June 2024
  6. CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC

    Despite great efforts in improving existing therapies, the outcome of patients with advanced radioresistant HPV-negative head and neck squamous cell...

    Fabian Geyer, Maximilian Geyer, ... Markus Nieberler in Scientific Reports
    Article Open access 09 April 2024
  7. High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia

    The World Health Organization [WHO] recommends a genotype-specific human papillomavirus [HPV] vaccination as a primary prevention strategy to control...

    Ayichew Seyoum, Berhanu Seyoum, ... Adane Mihret in Scientific Reports
    Article Open access 10 January 2024
  8. Characterization of type-specific HPV prevalence in a population of persistent cutaneous warts in Flanders, Belgium

    Cutaneous warts are benign skin lesions caused by the human papillomavirus (HPV). Even though they are considered benign, they can have a...

    Nina Redzic, A. Rita Pereira, ... Davy Vanden Broeck in Scientific Reports
    Article Open access 15 October 2023
  9. Comprehensive analysis of mitophagy in HPV-related head and neck squamous cell carcinoma

    Head and neck squamous cell carcinoma (HNSCC) is a common tumour type in otorhinolaryngology, and its occurrence is related to long-term exposure to...

    Li Yanan, Liang Hui, ... Sun Ran in Scientific Reports
    Article Open access 09 May 2023
  10. Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life

    To assess the dynamics of human papillomavirus (HPV) serology, we analyzed HPV6-,11-,16-,18-, and 45 antibodies in infants during the first 36 months...

    Stina Syrjänen, Tim Waterboer, ... Seija Grenman in Scientific Reports
    Article Open access 09 February 2022
  11. Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort

    High-risk human papillomavirus (HR-HPV) is the primary carcinogen in uterine cervical carcinoma. While genotype-specific carcinogenic risks have been...

    Juhun Lee, Dong Ja Kim, Hyun Jung Lee in Scientific Reports
    Article Open access 25 June 2024
  12. Machine learning prediction of antiviral-HPV protein interactions for anti-HPV pharmacotherapy

    Persistent infection with high-risk types Human Papillomavirus could cause diseases including cervical cancers and oropharyngeal cancers....

    Hui-Heng Lin, Qian-Ru Zhang, ... Hongyan Xu in Scientific Reports
    Article Open access 21 December 2021
  13. A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care

    Cervical cancer is a leading cause of death for women in low-resource settings despite being preventable through human papillomavirus (HPV)...

    Megan M. Chang, Ariel Ma, ... Rebecca Richards-Kortum in Scientific Reports
    Article Open access 21 November 2023
  14. Using HPV-meta for human papillomavirus RNA quality detection

    In the era of cervical cancer elimination, accurate and validated pipelines to detect human papillomavirus are essential to elucidate and understand...

    Agustin Ure, Dhananjay Mukhedkar, Laila Sara Arroyo Mühr in Scientific Reports
    Article Open access 29 July 2022
  15. Sexual practices and HPV infection in unvaccinated young adults

    The present study aimed to evaluate the association of genital and oral HPV infection among different sexual practices in both sexes. In total, 6388...

    Sílvia Pauli, Natália Luiza Kops, ... Eliana Wendland in Scientific Reports
    Article Open access 20 July 2022
  16. Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa

    Human papillomavirus (HPV)-based screen-and-treat (SAT) is recommended but implementation presents operational challenges. We implemented HPV-SAT at...

    Lynette Denny, Rakiya Saidu, ... Louise Kuhn in Scientific Reports
    Article Open access 27 September 2023
  17. Contributions of viral oncogenes of HPV-18 and hypoxia to oxidative stress and genetic damage in human keratinocytes

    Infection with high-risk human papillomaviruses like HPV-16 and HPV-18 is highly associated with the development of cervical and other cancers....

    Jimena Hochmann, Magdalena Millán, ... Miguel Arocena in Scientific Reports
    Article Open access 18 October 2023
  18. Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope

    To relieve the limitations of the human papillomavirus (HPV) vaccines based on L1 capsid protein, vaccine formulations based on RG1 epitope of HPV L2...

    Maryam Mashhadi Abolghasem Shirazi, Seyed Mehdi Sadat, ... Arash Arashkia in Scientific Reports
    Article Open access 05 October 2023
  19. 9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins

    Mucosal human papillomavirus (HPV) subtypes 16 and 18 are causative agents of cervical cancer, a leading cause of cancer-related deaths among women...

    Kazumasa Mogi, Yoshihiro Koya, ... Hiroaki Kajiyama in Scientific Reports
    Article Open access 06 November 2023
  20. Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis

    Circulating tumor HPV DNA (ctHPV16) assessed in liquid biopsy may be used as a marker of cancer in patients with HPV-associated oropharyngeal cancer...

    Marek Kentnowski, Alexander J. Cortez, ... Tomasz W. Rutkowski in Scientific Reports
    Article Open access 01 December 2023
Did you find what you were looking for? Share feedback.